Franklin Resources’s Crescent Biopharma CBIO Stock Holding History

Franklin Resources’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-958	Closed	-$226K	–	2912
2023 Q4	$226K	Sell	958 -1	-0.1%	-$155	﹤0.01%	2305
2023 Q3	$144K	Sell	959 -248	-21%	-$39.1K	﹤0.01%	2398
2023 Q2	$210K	Hold	1,207	–	–	﹤0.01%	2358
2023 Q1	$152K	Hold	1,207	–	–	﹤0.01%	2056
2022 Q4	$366K	Hold	1,207	–	–	﹤0.01%	1793
2022 Q3	$67K	Buy	1,207 +14	+1%	+$1.01K	﹤0.01%	2168
2022 Q2	$71K	Sell	1,193 -420	-26%	-$31.1K	﹤0.01%	2199
2022 Q1	$184K	Buy	1,613 +10	+0.6%	+$1.17K	﹤0.01%	2175
2021 Q4	$231K	Sell	1,603 -4	-0.2%	-$726	﹤0.01%	2183
2021 Q3	$352K	Buy	+1,607	New	+$340K	﹤0.01%	2027
2019 Q3	–	Sell	-17,188	Closed	-$20.5M	–	1535
2019 Q2	$20.5M	Sell	17,188 -419	-2%	-$501K	0.01%	742
2019 Q1	$21.9M	Sell	17,607 -2,073	-11%	-$2.37M	0.01%	723
2018 Q4	$18.6M	Sell	19,680 -483	-2%	-$581K	0.01%	719
2018 Q3	$29M	Sell	20,163 -1,475	-7%	-$2.23M	0.01%	677
2018 Q2	$34.9M	Buy	21,638 +556	+3%	+$956K	0.02%	626
2018 Q1	$34.2M	Buy	21,082 +1,788	+9%	+$3.72M	0.02%	632
2017 Q4	$32.4M	Buy	19,294 +703	+4%	+$930K	0.02%	661
2017 Q3	$26M	Hold	18,591	–	–	0.01%	723
2017 Q2	$20.7M	Buy	18,591 +8,591	+86%	+$7.1M	0.01%	779
2017 Q1	$5.43M	Hold	10,000	–	–	﹤0.01%	1090
2016 Q4	$6.1M	Sell	10,000 -100	-1%	-$62.4K	﹤0.01%	1054
2016 Q3	$7.22M	Hold	10,100	–	–	﹤0.01%	1038
2016 Q2	$7.34M	Hold	10,100	–	–	﹤0.01%	1025
2016 Q1	$6.02M	Hold	10,100	–	–	﹤0.01%	1067
2015 Q4	$5.78M	Buy	10,100 +1,497	+17%	+$992K	﹤0.01%	1106
2015 Q3	$4.82M	Sell	8,603 -316	-4%	-$228K	﹤0.01%	1150
2015 Q2	$7.09M	Hold	8,919	–	–	﹤0.01%	1110
2015 Q1	$7.42M	Hold	8,919	–	–	﹤0.01%	1104
2014 Q4	$6.42M	Sell	8,919 -261	-3%	-$204K	﹤0.01%	1134
2014 Q3	$6.37M	Sell	9,180 -1,547	-14%	-$1.25M	﹤0.01%	1138
2014 Q2	$9.04M	Buy	10,727 +1,780	+20%	+$1.77M	﹤0.01%	1079
2014 Q1	$14.6M	Buy	+8,947	New	+$10.8M	0.01%	933